vs
IF Bancorp, Inc.（IROQ）与Profound Medical Corp.（PROF）财务数据对比。点击上方公司名可切换其他公司
IF Bancorp, Inc.的季度营收约是Profound Medical Corp.的1.2倍（$7.3M vs $6.0M），IF Bancorp, Inc.净利率更高（18.1% vs -136.8%，领先154.9%）
美国银行控股公司合众银行是总部位于明尼阿波利斯、在特拉华州注册的美国跨国银行机构，截至2025年为美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构，主营银行、投资、抵押贷款等金融业务。
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
IROQ vs PROF — 直观对比
营收规模更大
IROQ
是对方的1.2倍
$6.0M
净利率更高
IROQ
高出154.9%
-136.8%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.3M | $6.0M |
| 净利润 | $1.3M | $-8.2M |
| 毛利率 | — | 66.8% |
| 营业利润率 | 24.9% | -123.3% |
| 净利率 | 18.1% | -136.8% |
| 营收同比 | 16.8% | — |
| 净利润同比 | 8.9% | — |
| 每股收益（稀释后） | $0.41 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IROQPROF
| Q4 25 | $7.3M | $6.0M | ||
| Q3 25 | $7.3M | $5.1M | ||
| Q2 25 | $6.9M | $2.0M | ||
| Q1 25 | $6.4M | $2.3M | ||
| Q4 24 | $6.3M | — | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $5.7M | — | ||
| Q1 24 | $5.4M | — |
净利润IROQPROF
| Q4 25 | $1.3M | $-8.2M | ||
| Q3 25 | $1.4M | $-8.0M | ||
| Q2 25 | $1.4M | $-15.7M | ||
| Q1 25 | $1.0M | $-10.7M | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $633.0K | — | ||
| Q2 24 | $431.0K | — | ||
| Q1 24 | $708.0K | — |
毛利率IROQPROF
| Q4 25 | — | 66.8% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 81.7% | ||
| Q1 25 | — | 79.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率IROQPROF
| Q4 25 | 24.9% | -123.3% | ||
| Q3 25 | 26.0% | -176.2% | ||
| Q2 25 | 29.1% | -696.9% | ||
| Q1 25 | 21.7% | -477.0% | ||
| Q4 24 | 26.8% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 9.3% | — | ||
| Q1 24 | 17.6% | — |
净利率IROQPROF
| Q4 25 | 18.1% | -136.8% | ||
| Q3 25 | 19.0% | -157.7% | ||
| Q2 25 | 21.0% | -792.3% | ||
| Q1 25 | 15.8% | -458.1% | ||
| Q4 24 | 19.4% | — | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | 7.6% | — | ||
| Q1 24 | 13.1% | — |
每股收益（稀释后）IROQPROF
| Q4 25 | $0.41 | $0.27 | ||
| Q3 25 | $0.43 | $0.26 | ||
| Q2 25 | $0.48 | $0.52 | ||
| Q1 25 | $0.31 | $0.36 | ||
| Q4 24 | $0.38 | — | ||
| Q3 24 | $0.20 | — | ||
| Q2 24 | $0.15 | — | ||
| Q1 24 | $0.22 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.8M | $59.7M |
| 总债务越低越好 | — | $4.5M |
| 股东权益账面价值 | $87.4M | $66.4M |
| 总资产 | $830.4M | $77.5M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资IROQPROF
| Q4 25 | $8.8M | $59.7M | ||
| Q3 25 | $8.0M | $24.8M | ||
| Q2 25 | $20.1M | $35.2M | ||
| Q1 25 | $8.9M | $46.4M | ||
| Q4 24 | $5.9M | — | ||
| Q3 24 | $7.8M | — | ||
| Q2 24 | $9.6M | — | ||
| Q1 24 | $16.1M | — |
总债务IROQPROF
| Q4 25 | — | $4.5M | ||
| Q3 25 | — | $4.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IROQPROF
| Q4 25 | $87.4M | $66.4M | ||
| Q3 25 | $84.5M | $32.1M | ||
| Q2 25 | $81.8M | $39.3M | ||
| Q1 25 | $78.9M | $50.8M | ||
| Q4 24 | $75.9M | — | ||
| Q3 24 | $78.8M | — | ||
| Q2 24 | $73.9M | — | ||
| Q1 24 | $72.4M | — |
总资产IROQPROF
| Q4 25 | $830.4M | $77.5M | ||
| Q3 25 | $862.3M | $42.3M | ||
| Q2 25 | $887.7M | $49.7M | ||
| Q1 25 | $879.1M | $60.9M | ||
| Q4 24 | $885.1M | — | ||
| Q3 24 | $893.4M | — | ||
| Q2 24 | $887.7M | — | ||
| Q1 24 | $905.0M | — |
负债/权益比IROQPROF
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.8M | $-6.6M |
| 自由现金流经营现金流 - 资本支出 | $1.7M | — |
| 自由现金流率自由现金流/营收 | 23.7% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | 1.36× | — |
| 过去12个月自由现金流最近4个季度 | $9.5M | — |
8季度趋势，按日历期对齐
经营现金流IROQPROF
| Q4 25 | $1.8M | $-6.6M | ||
| Q3 25 | $-539.0K | $-9.6M | ||
| Q2 25 | $6.8M | $-13.7M | ||
| Q1 25 | $1.8M | $-8.3M | ||
| Q4 24 | $-155.0K | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.3M | — | ||
| Q1 24 | $19.0K | — |
自由现金流IROQPROF
| Q4 25 | $1.7M | — | ||
| Q3 25 | $-582.0K | — | ||
| Q2 25 | $6.5M | — | ||
| Q1 25 | $1.8M | — | ||
| Q4 24 | $-226.0K | — | ||
| Q3 24 | $2.1M | — | ||
| Q2 24 | $2.0M | — | ||
| Q1 24 | $-67.0K | — |
自由现金流率IROQPROF
| Q4 25 | 23.7% | — | ||
| Q3 25 | -7.9% | — | ||
| Q2 25 | 95.1% | — | ||
| Q1 25 | 28.2% | — | ||
| Q4 24 | -3.6% | — | ||
| Q3 24 | 33.6% | — | ||
| Q2 24 | 35.7% | — | ||
| Q1 24 | -1.2% | — |
资本支出强度IROQPROF
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 4.3% | — | ||
| Q1 24 | 1.6% | — |
现金转化率IROQPROF
| Q4 25 | 1.36× | — | ||
| Q3 25 | -0.39× | — | ||
| Q2 25 | 4.69× | — | ||
| Q1 25 | 1.81× | — | ||
| Q4 24 | -0.13× | — | ||
| Q3 24 | 3.42× | — | ||
| Q2 24 | 5.30× | — | ||
| Q1 24 | 0.03× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
